Ateria Health Australia

Ateria Health is a biotechnology company specializing in gut health through the development of enzyme-rich natural products. The company's flagship product, Juvia, utilizes a proprietary Enzyme Rich Malt Extract (ERME) to break down carbohydrates in the small intestine, preventing the fermentation that causes symptoms of Irritable Bowel Syndrome (IBS). Based in the UK with a dedicated Australian subsidiary, Ateria Health focuses on bridging the gap between nutrition and pharmaceutical intervention. Their approach is backed by clinical research, including studies conducted in collaboration with King's College London. The company aims to provide sustainable, long-term relief for digestive issues without the need for restrictive diets like Low FODMAP.